Skip to main content

Evogene Raises Another $1.5M in Second Closing of Initial Placement

NEW YORK, Feb. 24 (GenomeWeb News) - Evogene has raised another $1.5 million in a second closing of its first private placement, the company said today.

 

The second closing brings the total amount of the first round to $3.5 million, after the first closing in March of 2003.

 

Evogene, based in Rehovot, Israel, combines predictive computational biology and plant genomics with classical breeding technologies to generate improved crops. The company was spun out of Compugen in 2002.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.